Lakefront Biotherapeutics (LKFT) Cash from Operations Growth (5y) (2022 - 2025)
Lakefront Biotherapeutics (LKFT) Cash from Operations Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.41 Bn | 466.62 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.15 Bn | 114.90 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.94 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.54 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 9.34% |
| Dec 31, 2024 | 3.47% |
| Mar 31, 2024 | -13.06% |
| Dec 31, 2023 | -15.61% |
| Mar 31, 2023 | -13.45% |
| Dec 31, 2022 | -43.64% |
| Mar 31, 2022 | -16.07% |